Fig. 2From: Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapyReceiving Operating Curve of the Prediction Model (ROC). The area under the curve (AUC) from Fig. 2. was 64%, indicating that the predictive model outperformed a random guess for determining which patient is likely to develop cardiac dysfunction within a year of trastuzumab therapyBack to article page